DHR vs Peers Stock Comparison

Danaher Prices as of Oct 26, 2026 Peers: Industry group
DHR Danaher Corp /De/
$232.95 +3.7% 1M +4.5% 1Y
Market cap
$163.74B
P/E
41.0x
Revenue (TTM)
$25.11B
Div. yield
0.65%
Life Sciences Tools Healthcare

Percentile Scorecard

DHR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisDHR
Valuation 72 #23 of 80
Growth 23 #57 of 74
Profitability 88 #9 of 67
Financial Health 37 #58 of 91
Shareholder Returns 68 #12 of 35
Overall 58
  • DHR ranked among 95 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodDHRSPY
1 month +3.7% -0.8%
3 months +18.5% +3.5%
6 months +29.0% +7.0%
Year to date +1.8% +12.2%
1 year +4.5% +13.0%
3 years +24.0% +86.3%
3 years, per year +7.4% +23.1%
5 years -23.7% +68.6%
5 years, per year -5.3% +11.0%
10 years +199.7% +258.0%
10 years, per year +11.6% +13.6%

Risk

MeasureDHRSPY
Volatility, 1Y 30.7% 12.7%
Downside volatility, 1Y 31.8% 12.7%
Beta vs S&P 500, 1Y 0.45 1.00
Return / volatility, 1Y 0.15 1.02
Max drawdown, 5Y -50.8% -25.4%
From 52-week high -3.8% -1.8%
52-week high $242.05 $779.14
52-week low $161.91 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleDHR
P/E now vs peer median 41.0xmedian 29.3x
P/S now vs peer median 6.5xmedian 2.6x
EV/EBITDA now vs peer median 24.3xmedian 17.4x
P/FCF now vs peer median 30.0xmedian 19.6x
P/B now vs peer median 3.1xmedian 1.3x
PEG now vs peer median -3.28median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsDHR
Revenue $25.11B
Gross profit $14.69B
Operating income $5.13B
Net income $4.00B
Free cash flow $5.47B
R&D $1.62B
EPS (diluted) $5.66
Cash & equivalents $4.35B
Total debt $26.56B
Shares (diluted) 707.60M
Enterprise value $147.56B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricDHR
P/E 41.0x
P/FCF 30.0x
P/Operating cash flow 24.7x
P/S 6.5x
P/B 3.1x
P/Tangible book 5.2x
EV/EBITDA 24.3x
EV/EBIT 36.3x
EV/Revenue 7.4x
EV/FCF 34.0x
EV/Operating cash flow 28.0x
PEG (3Y EPS CAGR) -3.28

Growth

14 metrics
MetricDHR
Revenue growth (1Y) 4.6%
Revenue CAGR (3Y) -0.5%
Gross profit growth (1Y) 2.6%
Gross profit CAGR (3Y) -0.9%
Operating income growth (1Y) 16.1%
Operating income CAGR (3Y) -7.1%
Net income growth (1Y) 17.3%
Net income CAGR (3Y) -14.3%
EPS growth (1Y) 19.2%
EPS CAGR (3Y) -12.5%
Operating cash flow growth (1Y) 7.6%
Operating cash flow CAGR (3Y) -7.6%
Free cash flow growth (1Y) 12.4%
Free cash flow CAGR (3Y) -9.0%

Profitability

14 metrics
MetricDHR
Gross margin 58.5%
EBITDA margin 30.5%
Operating margin 20.4%
Pretax margin 19.0%
Net margin 15.9%
FCF margin 21.8%
Operating cash flow margin 26.4%
Return on equity 7.6%
Return on assets 4.5%
Return on invested capital 5.7%
Return on capital employed 6.4%
Asset turnover 0.3x
Cash conversion (OCF / net income) 1.7x
Stock comp / revenue 1.2%

Financial Health

11 metrics
MetricDHR
Debt / assets 28.8%
Debt / equity 0.5x
Net debt / EBITDA 2.9x
Debt / FCF 4.9x
Liabilities / assets 43.1%
Equity / assets 56.9%
Interest coverage 17.6x
Current ratio 1.7x
Quick ratio 1.0x
Cash ratio 0.5x
Altman Z-score 3.72

Shareholder Returns

7 metrics
MetricDHR
Dividend yield 0.7%
Net buyback yield 1.8%
Shareholder yield 2.4%
Payout ratio (earnings) –
Payout ratio (FCF) –
Dividend growth (1Y) –
Dividend CAGR (3Y) –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusDHR
Forward P/E 25.8xFY2026
EPS, next fiscal year $9.03FY2026
EPS growth, next FY +15.8%FY2026
EPS growth, the year after +8.9%
Revenue, next fiscal year $27.12BFY2026
Revenue growth, next FY +10.4%FY2026
Revenue growth, the year after -1.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersDHR
Held by institutions 81.9%
Institutions holding 2,115
Change in shares held, QoQ +1.1%
Institutions buying 837
Institutions selling 1,015
Buyers to sellers 0.82

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which pays a higher dividend?

Only one of these companies pays a dividend: Danaher (DHR) 0.65%.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.